| dc.contributor.author |
Engin-Ustun, Y |
|
| dc.contributor.author |
Ustun, Y |
|
| dc.contributor.author |
Karabulut, AB |
|
| dc.contributor.author |
Dogan, K |
|
| dc.contributor.author |
Meydanli, MM |
|
| dc.contributor.author |
Sezgin, B |
|
| dc.date.accessioned |
2022-03-17T08:08:56Z |
|
| dc.date.available |
2022-03-17T08:08:56Z |
|
| dc.date.issued |
2007 |
|
| dc.identifier.uri |
http://hdl.handle.net/11616/56309 |
|
| dc.description.abstract |
Background: The aim of the current study was to investigate levels of adenosine deaminase in plasma of patients with hydatidiform mole. |
|
| dc.description.abstract |
Methods: Plasma adenosine deaminase levels were determined in 17 women with normal pregnant course, in 17 women with hydatidiform mole, and in 17 non-pregnant healthy volunteers. |
|
| dc.description.abstract |
Results: Mean adenosine deaminase activity in the hydatidiform mole group was 121.5 +/- 24.8 U/L, significantly higher than in the pregnant control (7.8 +/- 6.5 U/L; p < 0.0001) and non-pregnant control groups (6.4 +/- 7.4 U/L; p < 0.0001). A cutoff level of 40.5 U/L was found, with both sensitivity and specificity of 100%. |
|
| dc.description.abstract |
Conclusions: Adenosine deaminase may play a role in the development of hydatidiform mole. |
|
| dc.source |
CLINICAL CHEMISTRY AND LABORATORY MEDICINE |
|
| dc.title |
Increased adenosine deaminase in hydatidiform mole |
|